Micro RNA‐4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy-Reference-Cited by-同舟云学术

Micro RNA‐4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy

Published:2018-09-24 Issue:10 Volume:2 Page:1259-1273
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Zhang Tian‐Qi¹,Su Qun‐Qing¹,Huang Xiao‐Ying¹,Yao Jin‐Guang¹²,Wang Chao³,Xia Qiang⁴,Long Xi‐Dai¹⁴,Ma Yun⁵

Affiliation:

1. Department of Pathology the Affiliated Hospital of Youjiang Medical University for Nationalities Baise China

2. Department of Medicine Guangxi Science and Technology University Liuzhou China

3. Department of Medicine the Affiliated Hospital of Youjiang Medical University for Nationalities Baise China

4. Department of Liver Surgery Ren Ji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

5. Department of Pathology the Affiliated Tumor Hospital, Guangxi Medical University Nanning China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1245

Reference39 articles.

1. Cancer statistics in China, 2015

2. Aflatoxins: Food Sources Occurrence and Toxicological Effects 2014 Nova Science Publishers New York XD Long JD Yao Q Yang CH Huang P Liao LG Nong AG Faulkner Polymorphisms of DNA repair genes and toxicological effects of aflatoxin B1 exposure 125 156

3. Genetic Polymorphisms of DNA Repair Genes and DNA Repair Capacity Related to Aflatoxin B1 (AFB1)-Induced DNA Damages

4. DNA Repair Capacity-Related to Genetic Polymorphisms of DNA Repair Genes and Aflatoxin B1-Related Hepatocellular Carcinoma Among Chinese Population

5. Clinical Trial Simulations From a Model‐Based Meta‐Analysis of Studies in Patients With Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis;Exploration of Targeted Anti-tumor Therapy;2023-08-31

2. Upregulation of MicroRNA-937 Predicts a Poor Prognosis and Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion;Molecular Biotechnology;2021-09-14

3. The predictive potential of genetic single nucleotide polymorphisms in CBX4 for hepatocellular carcinoma survival;Frontiers in Bioscience-Landmark;2021

4. MicroRNA-4651 represses hepatocellular carcinoma cell growth and facilitates apoptosis via targeting FOXP4;Bioscience Reports;2020-06